Related Experiment Video
Updated: Jun 2, 2025

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
VISTA-induced tumor suppression by a four amino acid intracellular motif
Yan Zhao1, Tina Andoh1, Fatima Charles1
1Departments of Medicine and Molecular Biology, Cecil H. and Ida Green Center for Reproductive Sciences, UT Southwestern Medical Center, Dallas, TX, 75235.
Abstract:
VISTA is a key immune checkpoint receptor under investigation for cancer immunotherapy; however, its signaling mechanisms remain unclear. Here we identify a conserved four amino acid (NPGF) intracellular motif in VISTA that suppresses cell proliferation by constraining cell-intrinsic growth receptor signaling. The NPGF motif binds to the adapter protein NUMB and recruits Rab11 endosomal recycling machinery. We identify and characterize a class of triple-negative breast cancers with high VISTA expression and low proliferative index. In tumor cells with high VISTA levels, the NPGF motif sequesters NUMB at endosomes, which interferes with epidermal growth factor receptor (EGFR) trafficking and signaling to suppress tumor growth. These effects do not require canonical VISTA ligands, nor a functioning immune system. As a consequence of VISTA expression, EGFR receptor remains abnormally phosphorylated and cannot propagate ligand-induced signaling. Mutation of the VISTA NPGF domain reverts VISTA-induced growth suppression in multiple breast cancer mouse models. These results define a mechanism by which VISTA represses NUMB to control malignant epithelial cell growth and signaling. They also define distinct intracellular residues that are critical for VISTA-induced cell-intrinsic signaling that could be exploited to improve immunotherapy.
Insights
VISTA
Area of Science:
- Immunology
- Cancer Biology
- Cell Signaling
Background:
- VISTA is an immune checkpoint receptor investigated for cancer immunotherapy.
- Its precise signaling pathways are not fully understood.
- Understanding VISTA's cell-intrinsic functions is crucial for developing novel cancer treatments.
Purpose of the Study:
- To elucidate the intracellular signaling mechanisms of VISTA.
- To identify the role of VISTA in cancer cell proliferation.
- To explore VISTA's potential as a therapeutic target in breast cancer.
Main Methods:
- Identification of a conserved NPGF motif in VISTA.
- Investigating the interaction between VISTA, NUMB, and Rab11.
- Analyzing VISTA expression and EGFR signaling in triple-negative breast cancer models.
- Utilizing mouse models to assess the impact of VISTA NPGF domain mutations.
Main Results:
- A conserved NPGF motif in VISTA suppresses cell proliferation by regulating growth receptor signaling.
- VISTA's NPGF motif sequesters NUMB, disrupting epidermal growth factor receptor (EGFR) trafficking and signaling.
- High VISTA expression correlates with low proliferation in triple-negative breast cancers.
- Mutating the VISTA NPGF domain reverses VISTA-induced growth suppression in preclinical models.
Conclusions:
- VISTA utilizes the NPGF motif to control malignant epithelial cell growth and signaling via NUMB sequestration.
- This VISTA-mediated pathway suppresses tumor growth independently of immune system engagement.
- The identified intracellular VISTA signaling mechanism offers potential therapeutic targets for cancer immunotherapy.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation

